Immunohistochemical analysis of Mcl-1 and Bcl-2 proteins in normal and neoplastic lymph nodes

American Journal of Pathology

Volumn 145, Issue 3, 1994, Pages 515-525

  Krajewski, Stanislaw ^a   Bodrug, Sharon ^a   Gascoyne, Randy ^b   Berean, Ken ^c   Krajewska, Maryla ^a   Reed, John C ^a  

^a BURNHAM INSTITUTE   (United States)

^b BRITISH COLUMBIA CANCER AGENCY   (Canada)

^c VANCOUVER GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT;

ARTICLE; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; HODGKIN DISEASE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE HYPERPLASIA; LYMPHOMA; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; PROTEIN SYNTHESIS;

AMINO ACID SEQUENCE; BASE SEQUENCE; HUMANS; HYPERPLASIA; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; LYMPH NODES; LYMPHOMA, NON-HODGKIN; MOLECULAR SEQUENCE DATA; NEOPLASM PROTEINS; POLYMERASE CHAIN REACTION; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; TONSIL;

EID: 0027956645     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Reed JC: Bcl-2 and the regulation of programmed cell death. J Cell Biol 1994, 124:1-6
2. Tsujimoto YJ, Cossman E, Jaffe E, Croce C: Involvement of the bcl-2 gene in human follicular lymphoma. Science 1985, 228:1440-1443
3. Tsujimoto Y, Croce CM: Analysis of the structure, tran-scripts, and protein products of bcl-2, the gene involved in human follicular lymphoma. Proc Natl Acad Sci USA 1986, 83:5214-5218
4. Reed J, Tsujimoto Y, Epstein S, Cuddy M, Slabiak T, Nowell P, Croce C: Regulation of bcl-2 gene expression in lymphoid cell lines containing t(14;18) or normal #18 chromosomes. Oncogene Res 1989, 4:271-282
5. Seto M, Jaeger U, Hockett RD, Graninger W, Bennett S, Goldman P, Korsmeyer SJ: Alternative promoters and exons, somatic mutation, and deregulation of Bcl-2/lg fusion gene in lymphoma. EMBO J 1988, 7:123-131
6. Pezzella, Tse AFD, Cordell JL, Pulford KAF, Gatter KC, Mason DY: Expression of the Bcl-2 oncogene protein is not specific for the 14; 18 chromosomal translocation. Am J Pathol 1990, 137:225-232
7. MacLennan ICM, Gray D: Antigen-driven selection of virgin and memory B cells, Immunol Rev 1986, 91: 61-83
8. Ngan B-Y, Chen-Levy Z, Weiss LM, Warnke RA, Cleary ML: Expression in non-Hodgkin's lymphoma of the bcl-2 protein associated with the t(14;18) chromosomal translocation. N Engl J Med 1988, 318:1638
9. Boise LH, Gonåalez-Garcia M, Postema CE, Ding L, Lindsten T, Turka LA, Mao X, Nunez G, Thompson CB: bcl-x, a bcl-2 related gene that functions as a dominant regulator of apoptotic cell death. Cell 1993, 74: 597-608
10. Oltari Z, Milliman C, Korsmeyer SJ: Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 1993, 74:609-619
11. Kozopas KM, Yang T, Buchan HL, Zhou P, Craig RW: MCL-1, a gene expressed in programmed myeloid cell differentiation, has sequence similarity to Bcl-2. Proc Natl Acad Sci USA 1993, 90:3516-3520
12. Chen-Levy S, Cleary M: Membrane topology of the Bcl-2 proto-oncogenic protein demonstrated in vitro. J Biol Chem 1990, 265:4929-4933
13. Tanaka S, Saito K, Reed JC: Structure-function analysis of the apoptosis-suppressing Bcl-2 oncoprotein: substitution of a heterologous transmembrane domain restores function to truncated Bcl-2 proteins. J Biol Chem 1993, 268:10920-10926
14. Rogers S, Wells R, Rechsteiner M: Amino-acid sequences common to rapidly degraded proteins: the PEST hypothesis. Science 1986, 234:364-368
15. Kitada S, Miyashita T, Tanaka S, Reed JC: Investigation of antisense oligonucleotides targeted against bcl-2 RNAs. Antisense Res Dev 1993, 3:157-169
16. Monaghan P, Robertson D, Amos AS, Dyer MJS, Mason DY, Greaves MF: Ultrastructural localization of Bcl-2 protein. J Histochem Cytochem 1992, 40:1819-1825
17. Jacobson MD, Burne JF, King MP, Miyashita T, Reed JC, Raff MC: Apoptosis and bcl-2 protein in cells without mitochondrial DNA. Nature 1993, 361:365-368
18. Krajewski S, Tanaka S, Takayama S, Schibler MJ, Fenton W, Reed JC: Investigations of the subcellular distribution of the BCL-2 oncoprotein: residence in the nuclear envelope, endoplasmic reticulum, and outer mitochondrial membranes. Cancer Res 1993, 53: 4701-4714
19. de Jong D, Prins FA, Mason DY, Reed JC, van Ommen GB, Kluin PM: Subcellular localization of the bcl-2 protein in malignant and normal lymphoid cells. Cancer Res 1994, 54:256-260
20. Reed J, Meister L, Cuddy M, Geyer C, Pleasure D: Differential expression of the Bcl-2 proto-oncogene in neuroblastomas and other human neural tumors. Cancer Res 1991, 51:6529-6538
21. Munakata S, Hendricks JB: Effect of fixation time and microwave oven heating time on retrieval of the Ki-67 antigen from paraffin-embedded tissue. J Histochem Cytochem 1993, 41:1241-1246
22. Sato TS, Irie S, Krajewski S, Reed JC: Cloning and sequencing of cDNA encoding rat Bcl-2 protein. Gene, 1994, 140:291-292
23. Baffy G, Miyashita T, Williamson JR, Reed JC: Apoptosis induced by withdrawal of interleukin-3 [IL-3] from an IL-3-dependent hematopoietic cell line is associated with repartitioning of intracellular calcium and is blocked by enforced Bcl-2 oncoprotein production. J Biol Chem 1993, 268:6511-6519
24. Dyer MJS, Fischer P, Nacheva E, Labastide W, Karpas A: A new human B-cell non-Hodgkin's lymphoma cell line (Karpas 422) exhibiting both t(14;18) and t(4;11) chromosomal translocations. Blood 1990, 75:708-714
25. Hockenbery DM, Zutter M, Hickey W, Nahm M, Korsmeyer SJ: Bcl-2 protein is topographically restricted in tissues characterized by apoptotic cell death. Proc Natl Acad Sci USA 1991, 88:6961-6965
26. Zutter M, Hockenbery D, Silverman, GA, Korsmeyer SJ. Immunolocalization of the Bcl-2 protein within hematopoietic neoplasms. Blood 1991, 78:1062-1068
27. Nunez G, Hockenbery D, McDonnell TJ, Sorensen CM, Korsmeyer SJ: Bcl-2 maintains B cell memory. Nature 1991, 353:71-73
28. Strasser A, Whittingham S, Vaux DL, Bath ML, Adams JM, Cory S, Harris AW: Enforced Bcl-2 expression in B-lymphoid cells prolongs antibody responses and elicits autoimmune disease. Proc Natl Acad Sci USA 1991, 88:8661-8665
29. Liu Y-J, Cairns JA, Holder MJ, Abbot SD, Jansen KU, Bonnefoy J-Y, Gordon J, MacLennan ICM: Recombinant 25-kDa CD23 and interleukin-1a promote the survival of germinal center B cells: evidence for bifurcation in the development of centrocytes rescued from apoptosis. Eur J Immunol 1991a, 21:1107-1114
30. Liu Y-J, Mason DY, Johnson GD, Abbot S, Gregory CD, Hardie DL, Gordon J, MacLennan ICM: Germinal center cells express bcl-2 protein after activation by signals which prevent their entry into apoptosis. Eur J Immunol 1991b, 21:1905-1910
31. Korsmeyer SJ: Bcl-2 initiates a new category of oncogenes: regulators of cell death. Blood 1992, 80:879-886
32. Zelenetz AD, Chu G, Galili N, Bangs CD, Horning SJ, Donlon TA, Cleary ML, Levy R: Enhanced detection of the t(14;18) translocation in malignant lymphoma using pulsed-field gel electrophoresis. Blood 1991, 178:1552
33. Drexler HG, Leber BF: The nature of the Hodgkin cell. Blut 1988, 56:135-137
34. Bobbins SL, Cotran RS. Pathological Basis of Disease, ed 2. Philadelphia, PA, WB Saunders Company, 1979, pp 773
35. Sato T, Hanada M, Bodrug S, Irie S, Iwama N, Boise L, Thompson C, Golemis E, Fong L, Wang H-G, Reed JC: Interactions among members of the Bcl-2 protein family analyzed by yeast two-hybrid system. Proc Natl Acad Sci USA, in press